These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 18978501)

  • 21. Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Cree BA; Kornyeyeva E; Goodin DS
    Ann Neurol; 2010 Aug; 68(2):145-50. PubMed ID: 20695007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A; Mitchell I; Patel S; Ives N; Rickards H
    Mov Disord; 2009 Nov; 24(15):2254-9. PubMed ID: 19845035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    Harel Y; Appleboim N; Lavie M; Achiron A
    J Neurol Sci; 2009 Jan; 276(1-2):38-40. PubMed ID: 18817930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reflexology for the treatment of pain in people with multiple sclerosis: a double-blind randomised sham-controlled clinical trial.
    Hughes CM; Smyth S; Lowe-Strong AS
    Mult Scler; 2009 Nov; 15(11):1329-38. PubMed ID: 19825891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
    Trebst C; Stangel M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):463-9. PubMed ID: 16052440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
    Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
    Wingerchuk DM; Benarroch EE; O'Brien PC; Keegan BM; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M
    Neurology; 2005 Apr; 64(7):1267-9. PubMed ID: 15824361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
    Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
    Tomida I; Azuara-Blanco A; House H; Flint M; Pertwee RG; Robson PJ
    J Glaucoma; 2006 Oct; 15(5):349-53. PubMed ID: 16988594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial.
    Solari A; Motta A; Mendozzi L; Pucci E; Forni M; Mancardi G; Pozzilli C;
    J Neurol Sci; 2004 Jul; 222(1-2):99-104. PubMed ID: 15240203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
    Möller F; Poettgen J; Broemel F; Neuhaus A; Daumer M; Heesen C
    Mult Scler; 2011 Aug; 17(8):1002-9. PubMed ID: 21561959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reported memory problems in multiple sclerosis: influence of psychiatric status and normative dissociative experiences.
    Bruce JM; Bruce AS; Hancock L; Lynch S
    Arch Clin Neuropsychol; 2010 Feb; 25(1):39-48. PubMed ID: 19959565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.